[ Price : $8.95]
Federal Register Notice: FDA releases a guidance, Limiting the Use of Certain Phthalates as Excipients in CDER-Regulated Products.[ Price : $8.95]
Federal Register Proposed rule: FDA proposes to revise the animal drug regulations to standardize, simplify, and clarify the deter...[ Price : $8.95]
CDRH releases its six strategic priorities for 2013.[ Price : $8.95]
FDA and AstraZeneca reach agreement on label changes for Faslodex injection that updates results from the companys CONFIRM trial i...[ Price : $8.95]
An FDA report discusses the 35 new molecular entities the agency approved in FY 2012.[ Price : $8.95]
Lawyers from Skadden and Foley Hoag examine the future of FDA and Justice Department enforcement actions in the wake of this weeks...[ Price : $8.95]
FDA and Peregrine Pharmaceuticals reach agreement on the design of a single registration drug trial for Cotara in patients with re...[ Price : $8.95]
FDA Webview editor Jim Dickinson analyzes FDAs loss of a potent off-label drug marketing case, calling it a staggering strategic b...